Herpetic Neuralgia News

The Shingles Vaccine Returns - New York Times (blog)



The Shingles Vaccine Returns 
New York Times (blog)
In some, the intense pain can persist for months after the rash clears, a complication called postherpetic neuralgia. With more than a million cases annually and a high rate of serious complications in older patients, the development of a vaccine was a ...

and more » 


How to Avoid Shingles After Age 50 - Patch.com



Postnoon
 
How to Avoid Shingles After Age 50 
Patch.com
Post-herpetic neuralgia, the nerve pain that sometimes follows shingles, and which can last anywhere from weeks to years. The shingles theme continued the next day when I saw my primary-care doctor for a routine annual physical.
Care can spare you the scar Postnoon

all 6 news articles » 


Shingles vaccine available - Poughkeepsie Journal



Shingles vaccine available 
Poughkeepsie Journal
It most often starts as a burning skin rash that can eventually lead to severe pain, known as post-herpetic neuralgia. The pain can last for months or years after the rash goes away. The only way to reduce the risk of getting shingles is to get ...

 


Health Watch: Talk to your doctor about the shingles vaccine - Ithaca Journal



Newsweek
 
Health Watch: Talk to your doctor about the shingles vaccine 
Ithaca Journal
This condition is called post-herpetic neuralgia (PHN). It can last for months or years and the incidence of PHN increases with age. There are no curative strategies for PHN, but there are medications available that can palliate some of the associated ...
If you're in pain and have rash, it may be shingles The Durango Herald

all 11 news articles » 


Millennium Laboratories Sponsors Symposium on Managing Risk and Optimizing - MarketWatch (press release)



Millennium Laboratories Sponsors Symposium on Managing Risk and Optimizing 
MarketWatch (press release)
Millions of other Americans suffer regularly with chronic pain associated with fibromyalgia, rheumatoid arthritis pain, cancer-related pain, post-herpetic neuralgia pain, and pain secondary to HIV or AIDS[i],[ii],[iii],[iv],[v],[vi].

and more » 


Antidote: Merck's shingles homerun - Medical Marketing and Media



Antidote: Merck's shingles homerun 
Medical Marketing and Media
The rash is painful, and if it progresses to post-herpetic neuralgia, potentially disabling. Before all we could do is use topical analgesics and the anti-viral drug acyclovir to blunt its attack. Zostavax is the only vaccine available to keep shingles ...
Shingles vaccination production increases; CDC recommending shot for Americans ... Cumberland Times-News

all 3 news articles » 


Millennium Laboratories Sponsors Symposium on Managing Risk and Optimizing - Sacramento Bee



Millennium Laboratories Sponsors Symposium on Managing Risk and Optimizing 
Sacramento Bee
Millions of other Americans suffer regularly with chronic pain associated with fibromyalgia, rheumatoid arthritis pain, cancer-related pain, post-herpetic neuralgia pain, and pain secondary to HIV or AIDS[i] , [ii] , [iii] , [iv] , [v] , [vi].

 


Ask the doctor: Shingles on my face has left me in agony - Daily Mail



Daily Mail
 
Ask the doctor: Shingles on my face has left me in agony 
Daily Mail
The awful problem you describe goes by the technical name of post-herpetic neuralgia. This searing, burning pain is the most significant complication of shingles. The condition is caused by the same virus that causes chicken pox, called herpes virus ...

and more » 


Millennium Laboratories Sponsors Symposium on Managing Risk and Optimizing - PR Newswire (press release)



Millennium Laboratories Sponsors Symposium on Managing Risk and Optimizing 
PR Newswire (press release)
Millions of other Americans suffer regularly with chronic pain associated with fibromyalgia, rheumatoid arthritis pain, cancer-related pain, post-herpetic neuralgia pain, and pain secondary to HIV or AIDS[i] , [ii] , [iii] , [iv] , [v] , [vi].

and more » 


5 Biotechnology Stocks With Upcoming Catalysts - Seeking Alpha



5 Biotechnology Stocks With Upcoming Catalysts 
Seeking Alpha
... stock is $1.91-$6.06 XenoPort is set to receive a decision regarding its supplementary new dug application for Horizant (currently approved for the treatment of restless legs syndrome) in the treatment of post-herpetic neuralgia (PHN) on June 9.